Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. SC 13D/A Stake Beneficial Ownership Report
  2. 4 Open-market sale Director sold 8,965 shares at $86.98 ($779,777)
  3. 4 Open-market sale Director sold 1,155 shares at $84.89 ($98,045)
  4. 4 Open-market sale Director sold 22,845 shares at an average $85.36 ($1,949,996)
  5. SC 13G Stake Amended Statement of Ownership
  6. SC 13G Stake Amended Statement of Ownership
  7. 4 Open-market sale Director sold 60,000 shares at an average $92.51 ($5,550,644)
  8. 4 Open-market sale Chief Financial Officer sold 12,000 shares at an average $92.26 ($1,107,068)
  9. 4 Open-market sale President sold 25,000 shares at an average $92.62 ($2,315,578)
  10. 4 Shares withheld for taxes Chief Executive Officer gave up 779 shares (to pay taxes)
  11. 4 Open-market sale President sold 25,000 shares at $100.00 ($2,500,000)
  12. 4 Other acquisition Director acquired 71 shares (other)
  13. 4 Open-market sale Chief Financial Officer sold 12,000 shares at an average $86.74 ($1,040,919)
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. SC 13D/A Stake Beneficial Ownership Report
  18. 4 Open-market sale President sold 25,000 shares at $90.00 ($2,250,000)
  19. 4 Open-market sale Director sold 20,000 shares at an average $82.39 ($1,647,730)
  20. 4 Open-market sale President sold 50,000 shares at $80.00 ($4,000,000)

Page 24 of 45 · 883 filings